Analyst Consensus ?
ConsensusHold49 ratings
Bullish2653.1%
Neutral2040.8%
Bearish36.1%
1 unmapped firm rating excluded from the percentages.
Dollar General Corporation · DG · FY2026 Q1 · Calendar Q2 2026
Dollar General Beats EPS, Raises FY26 Guidance as $1 Value Strategy Drives Comps
Dollar General delivered a Q1 EPS beat and raised full-year guidance, but revenue narrowly missed consensus and same-store sales growth decelerated meaningfully from Q4's 4.3% to 2%. The $1 price-point strategy and delivery expansion are proving durable comp drivers, each contributing roughly 70 basis points to comparable sales growth. Margin expansion continues, and management struck a confident tone. The stock fell 3.3% on the report before drifting more than 8% higher in subsequent weeks, suggesting the market initially fixated on the sales deceleration but ultimately rewarded the raised guidance and value-led comp trajectory. Analyst concerns center on whether the comp momentum and margin gains are sustainable as fuel costs and inflation press on Dollar General's core low-income customer.
Reported Before market openNYSEConsumer Defensive
$28.39B market cap
100quality score
Company context
Snapshot as of publicationDollar General Corporation is a prominent discount retail chain that offers a wide array of merchandise across the southern, southwestern, Midwestern, and eastern regions of the United States. Its extensive product assortment primarily features consumable items. This includes household essentials such as paper products, cleaning supplies, and laundry detergents; a wide array of food options, ranging from shelf-stable groceries like cereals, pasta, canned goods, condiments, and baking ingredients, to fresh and refrigerated perishables such as milk, eggs, bread, and frozen foods, as well as alcoholic beverages like beer and wine. The selection further encompasses popular snacks (candies, cookies, crackers, and carbonated drinks), health and beauty aids (over-the-counter medications, personal care items, cosmetics, dental, and foot care products), pet food and supplies, and tobacco products.…
Earnings scorecard
Reported versus consensus
Reported EPS
$2.00
Consensus $2
EPS surprise
+5.8%
Reported versus consensus
Reported revenue
$10.79B
Consensus $10.81B
Revenue surprise
-0.3%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$127.58Current
$80Low
$148.67Average
$273High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | In Line | In Line | Maintain | Jul 7, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 4, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jun 3, 2026 |
| Telsey Advisory Group | Market Perform | Market Perform | Maintain | Jun 3, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jun 3, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 3, 2026 |
| Loop Capital | Hold | Hold | Maintain | Jun 3, 2026 |
| Freedom Broker | Hold | Buy | Downgrade | Jun 3, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jun 3, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jun 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | Mar 13, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Dec 19, 2025 |
| JP Morgan | Overweight | Neutral | Upgrade | Dec 15, 2025 |
| UBS | Buy | Buy | Maintain | Dec 5, 2025 |
| Jefferies | Buy | Buy | Maintain | Dec 5, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 29, 2025 |
| Goldman Sachs | Neutral | Buy | Downgrade | Jun 24, 2025 |
| Keybanc | Sector Weight | Maintain | Jun 4, 2025 | |
| B of A Securities | Buy | Buy | Maintain | Jun 4, 2025 |
| Gordon Haskett | Reduce | Hold | Downgrade | Apr 10, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Mar 3, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 15, 2024 |
| HSBC | Hold | Reduce | Upgrade | Oct 16, 2023 |
| OTR Global | Mixed | Positive | Downgrade | Aug 23, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Aug 23, 2023 |
| Daiwa Capital | Neutral | Outperform | Downgrade | Jun 6, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jun 2, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jun 2, 2023 |
| Cleveland Research | Buy | Neutral | Upgrade | Jul 5, 2022 |
| RBC Capital | Sector Perform | Outperform | Downgrade | May 12, 2021 |
| CFRA | Strong Buy | Strong Buy | Maintain | May 28, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Aug 30, 2019 |
| Buckingham Research | Buy | Buy | Maintain | Aug 30, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Aug 27, 2018 |
| Bank of America | Neutral | Buy | Downgrade | Jan 13, 2017 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | Sep 7, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Aug 26, 2016 |
| Johnson Rice | Accumulate | Buy | Maintain | Aug 25, 2016 |
| MKM Partners | Buy | Buy | Maintain | May 27, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Mar 28, 2016 |
| Stifel | Buy | Buy | Maintain | Mar 28, 2016 |
| BB&T Capital | Buy | Hold | Upgrade | Nov 20, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 3, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Aug 17, 2014 |
| S&P Capital IQ | Sell | Buy | Downgrade | Jan 14, 2014 |
| Nomura | Buy | Buy | Maintain | Aug 1, 2013 |
| Wedbush | Outperform | Outperform | Maintain | Mar 26, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $127.58. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Telsey Advisory | Joseph Feldman | $125 | $103.06 | -2.0% | Jun 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $115 | $102.56 | -9.9% | Jun 3, 2026 |
| Evercore ISI | Analyst unavailable | $140 | $103.77 | +9.7% | Jun 3, 2026 |
| BMO Capital | Kelly Bania | $120 | $106.37 | -5.9% | Jun 3, 2026 |
| Bernstein | Analyst unavailable | $149 | $106.37 | +16.8% | Jun 3, 2026 |
| Morgan Stanley | Analyst unavailable | $132 | $106.37 | +3.5% | Jun 3, 2026 |
| Piper Sandler | Analyst unavailable | $118 | $106.37 | -7.5% | Jun 3, 2026 |
| Raymond James | Bobby Griffin | $145 | $106.37 | +13.7% | Jun 3, 2026 |
| Barclays | Seth Sigman | $148 | $106.37 | +16.0% | Jun 3, 2026 |
| Truist Financial | Analyst unavailable | $114 | $107.59 | -10.6% | Jun 2, 2026 |
| Truist Financial | Scot Ciccarelli | $109 | $105.62 | -14.6% | May 27, 2026 |
| Deutsche Bank | Analyst unavailable | $110 | $103.64 | -13.8% | May 27, 2026 |
| Telsey Advisory | Joseph Feldman | $140 | $117.89 | +9.7% | Mar 24, 2026 |
| UBS | Michael Lasser | $163 | $134.19 | +27.8% | Mar 16, 2026 |
| Guggenheim | John Heinbockel | $160 | $132.68 | +25.4% | Mar 13, 2026 |
| Jefferies | Corey Tarlowe | $170 | $135.95 | +33.2% | Mar 12, 2026 |
| Truist Financial | Scot Ciccarelli | $139 | $135.95 | +9.0% | Mar 12, 2026 |
| BNP Paribas | Chris Bottiglieri | $127 | $135.42 | -0.5% | Mar 12, 2026 |
| Wolfe Research | Spencer Hanus | $165 | $138.72 | +29.3% | Mar 12, 2026 |
| Oppenheimer | Analyst unavailable | $170 | $152.9 | +33.2% | Feb 24, 2026 |
| Redburn Partners | Analyst unavailable | $111 | $153.84 | -13.0% | Feb 17, 2026 |
| UBS | Analyst unavailable | $168 | $147.1 | +31.7% | Feb 6, 2026 |
| Evercore ISI | Analyst unavailable | $145 | $143.51 | +13.7% | Feb 3, 2026 |
| Truist Financial | Analyst unavailable | $144 | $151.73 | +12.9% | Jan 16, 2026 |
| Jefferies | Corey Tarlowe | $165 | $142.74 | +29.3% | Jan 12, 2026 |
| Deutsche Bank | Analyst unavailable | $170 | $143.89 | +33.2% | Jan 8, 2026 |
| Barclays | Analyst unavailable | $151 | $143.51 | +18.4% | Jan 8, 2026 |
| Bernstein | Analyst unavailable | $150 | $136.82 | +17.6% | Jan 5, 2026 |
| Wells Fargo | Analyst unavailable | $125 | $136.68 | -2.0% | Dec 19, 2025 |
| Truist Financial | Analyst unavailable | $129 | $131.23 | +1.1% | Dec 5, 2025 |
| Telsey Advisory | Analyst unavailable | $130 | $131.76 | +1.9% | Dec 5, 2025 |
| Jefferies | Analyst unavailable | $142 | $131.13 | +11.3% | Dec 5, 2025 |
| Morgan Stanley | Analyst unavailable | $135 | $131 | +5.8% | Dec 5, 2025 |
| Evercore ISI | Analyst unavailable | $130 | $127.98 | +1.9% | Dec 5, 2025 |
| UBS | Michael Lasser | $143 | $129.84 | +12.1% | Dec 5, 2025 |
| UBS | Analyst unavailable | $129 | $132.87 | +1.1% | Dec 5, 2025 |
| BMO Capital | Analyst unavailable | $130 | $125.29 | +1.9% | Dec 5, 2025 |
| Guggenheim | John Heinbockel | $140 | $132.24 | +9.7% | Dec 5, 2025 |
| Piper Sandler | Analyst unavailable | $129 | $125.29 | +1.1% | Dec 5, 2025 |
| Raymond James | Bobby Griffin | $135 | $125.29 | +5.8% | Dec 5, 2025 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $140 | $122.89 | +9.7% | Dec 4, 2025 |
| Evercore ISI | Analyst unavailable | $105 | $108.58 | -17.7% | Dec 2, 2025 |
| Guggenheim | John Heinbockel | $125 | $108.77 | -2.0% | Nov 28, 2025 |
| Wolfe Research | Analyst unavailable | $139 | $106.14 | +9.0% | Sep 17, 2025 |
| Telsey Advisory | Analyst unavailable | $123 | $108.76 | -3.6% | Aug 29, 2025 |
| Morgan Stanley | Analyst unavailable | $125 | $108.76 | -2.0% | Aug 29, 2025 |
| Raymond James | Bobby Griffin | $130 | $111.71 | +1.9% | Aug 29, 2025 |
| Bernstein | Zhihan Ma | $134 | $111.71 | +5.0% | Aug 29, 2025 |
| Truist Financial | Scot Ciccarelli | $120 | $111.71 | -5.9% | Aug 29, 2025 |
| Piper Sandler | Analyst unavailable | $117 | $108.76 | -8.3% | Aug 29, 2025 |
| Wells Fargo | Analyst unavailable | $115 | $108.76 | -9.9% | Aug 29, 2025 |
| Barclays | Analyst unavailable | $127 | $111.71 | -0.5% | Aug 29, 2025 |
| Truist Financial | Scot Ciccarelli | $119 | $113.83 | -6.7% | Aug 13, 2025 |
| Bernstein | Zhihan Ma | $120 | $101.39 | -5.9% | May 23, 2025 |
| Telsey Advisory | Analyst unavailable | $85 | $76.24 | -33.4% | Mar 6, 2025 |
| Deutsche Bank | Analyst unavailable | $80 | $71.89 | -37.3% | Mar 3, 2025 |
| Loop Capital Markets | Anthony Chukumba | $80 | $75.9 | -37.3% | Dec 2, 2024 |
| Bernstein | Zhihan Ma | $98 | $81.13 | -23.2% | Oct 21, 2024 |
| Argus Research | Chris Graja | $125 | $82.35 | -2.0% | Sep 9, 2024 |
| Barclays | Seth Sigman | $102 | $82.97 | -20.1% | Sep 3, 2024 |
| Goldman Sachs | Kate McShane | $122 | $84.1 | -4.4% | Aug 30, 2024 |
| Bank of America Securities | Robert Ohmes | $95 | $85.84 | -25.5% | Aug 30, 2024 |
| Gordon Haskett Capital Corporation | Chuck Grom | $90 | $86.98 | -29.5% | Aug 30, 2024 |
| Raymond James | Bobby Griffin | $120 | $84.03 | -5.9% | Aug 30, 2024 |
| Loop Capital Markets | Anthony Chukumba | $90 | $84.03 | -29.5% | Aug 30, 2024 |
| Telsey Advisory | Joseph Feldman | $103 | $84.03 | -19.3% | Aug 30, 2024 |
| Morgan Stanley | Simeon Gutman | $100 | $84.03 | -21.6% | Aug 30, 2024 |
| Truist Financial | Scot Ciccarelli | $130 | $123.6 | +1.9% | Aug 26, 2024 |
| Argus Research | Chris Graja | $170 | $128.36 | +33.2% | Jul 15, 2024 |
| Loop Capital Markets | Anthony Chukumba | $140 | $130.28 | +9.7% | Jun 28, 2024 |
| BMO Capital | Kelly Bania | $140 | $132.8 | +9.7% | May 31, 2024 |
| Loop Capital Markets | Anthony Chukumba | $135 | $127.94 | +5.8% | May 31, 2024 |
| Truist Financial | Scot Ciccarelli | $135 | $127.94 | +5.8% | May 31, 2024 |
| Piper Sandler | Peter Keith | $141 | $127.94 | +10.5% | May 31, 2024 |
| Telsey Advisory | Joseph Feldman | $168 | $127.94 | +31.7% | May 31, 2024 |
| Guggenheim | John Heinbockel | $155 | $127.94 | +21.5% | May 31, 2024 |
| Deutsche Bank | Paul Trussell | $158 | $127.94 | +23.8% | May 31, 2024 |
| Evercore ISI | Michael Montani | $150 | $127.94 | +17.6% | May 31, 2024 |
| Jefferies | Corey Tarlowe | $160 | $128.18 | +25.4% | May 30, 2024 |
| Argus Research | Chris Graja | $175 | $155.54 | +37.2% | Mar 28, 2024 |
| Guggenheim | John Heinbockel | $165 | $151.95 | +29.3% | Mar 15, 2024 |
| Truist Financial | Scot Ciccarelli | $140 | $151.95 | +9.7% | Mar 15, 2024 |
| BMO Capital | Kelly Bania | $160 | $151.95 | +25.4% | Mar 15, 2024 |
| Wells Fargo | Edward Kelly | $155 | $151.95 | +21.5% | Mar 15, 2024 |
| Evercore ISI | Michael Montani | $158 | $151.95 | +23.8% | Mar 15, 2024 |
| Telsey Advisory | Joseph Feldman | $170 | $151.95 | +33.2% | Mar 15, 2024 |
| Goldman Sachs | Kate McShane | $169 | $151.95 | +32.5% | Mar 15, 2024 |
| CFRA | Arun Sundaram | $172 | $150.06 | +34.8% | Mar 14, 2024 |
| Morgan Stanley | Simeon Gutman | $160 | $134.64 | +25.4% | Jan 16, 2024 |
| Barclays | Seth Sigman | $154 | $134.68 | +20.7% | Jan 4, 2024 |
| Telsey Advisory | Joseph Feldman | $135 | $127.42 | +5.8% | Dec 8, 2023 |
| Wells Fargo | Edward Kelly | $122 | $133.92 | -4.4% | Dec 7, 2023 |
| Telsey Advisory | Joseph Feldman | $124 | $111.16 | -2.8% | Oct 13, 2023 |
| Truist Financial | Scot Ciccarelli | $142 | $106.26 | +11.3% | Sep 29, 2023 |
| Roth Capital | David Bellinger | $225 | $156.57 | +76.4% | Aug 28, 2023 |
| Telsey Advisory | Joseph Feldman | $185 | $161.58 | +45.0% | Aug 21, 2023 |
| Loop Capital Markets | Anthony Chukumba | $200 | $158.74 | +56.8% | Jun 5, 2023 |
| Oppenheimer | Rupesh Parikh | $155 | $161.86 | +21.5% | Jun 2, 2023 |
| Telsey Advisory | Joseph Feldman | $242 | $203.84 | +89.7% | May 30, 2023 |
| Argus Research | Chris Graja | $250 | $218.22 | +96.0% | Apr 21, 2023 |
| Telsey Advisory | Joseph Feldman | $285 | $257.14 | +123.4% | Nov 25, 2022 |
| Raymond James | Bobby Griffin | $285 | $237.44 | +123.4% | Aug 26, 2022 |
| Telsey Advisory | Joseph Feldman | $280 | $246.04 | +119.5% | Aug 25, 2022 |
| Truist Financial | Scot Ciccarelli | $262 | $247.87 | +105.4% | Aug 24, 2022 |
| Morgan Stanley | Simeon Gutman | $250 | $232.25 | +96.0% | Jun 16, 2022 |
| Truist Financial | Scot Ciccarelli | $178 | $187.6 | +39.5% | May 22, 2022 |
| Gordon Haskett Capital Corporation | Chuck Grom | $210 | $187.6 | +64.6% | May 22, 2022 |
| Jefferies | Corey Tarlowe | $285 | $248.77 | +123.4% | Apr 18, 2022 |
| BMO Capital | Kelly Bania | $265 | $226.3 | +107.7% | Mar 28, 2022 |
| J.P. Morgan | Matthew Boss | $273 | $221.4 | +114.0% | Mar 17, 2022 |
| Deutsche Bank | Krisztina Katai | $242 | $221.4 | +89.7% | Mar 17, 2022 |
| Oppenheimer | Rupesh Parikh | $240 | $213.73 | +88.1% | Mar 15, 2022 |
| Gordon Haskett Capital Corporation | Charles Grom | $230 | $201.61 | +80.3% | Feb 10, 2022 |
| Citigroup | Paul Lejuez | $258 | $203.83 | +102.2% | Jan 28, 2022 |
| Truist Financial | Scot Ciccarelli | $228 | $217.08 | +78.7% | Jan 14, 2022 |
| R5 Capital | Scott Mushkin | $218 | $220 | +70.9% | Nov 8, 2021 |
| UBS | Michael Lasser | $245 | $233.18 | +92.0% | Aug 23, 2021 |
| Bank of America Securities | Robert Ohmes | $190 | $195.55 | +48.9% | May 24, 2021 |
| Guggenheim | John Heinbockel | $250 | $214.97 | +96.0% | Apr 19, 2021 |
Track every rating change on DG the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-3.3%
Event window
SPY move
+0.1%
Same window
Abnormal move
-3.5%
Stock minus SPY
Volume
2.1×
Versus trailing sessions
Subsequent drift
+8.4%
Up to 20 sessions
DGSPY benchmark
Follow DG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Net sales rose 3.4% to $10.8 billion, decelerating from 5.9% growth in Q4. Same-store sales increased 2% (vs 4.3% in Q4), driven by traffic growth and a 0.5-point increase in basket size. EPS came in at $2.00 versus the $1.89 consensus, a 5.8% surprise, while revenue narrowly missed at $10.79B versus $10.81B expected. The $1 price point contributed roughly 70 basis points to comp sales growth, and delivery also added approximately 70 basis points. The company opened 190 new U.S. stores in Q1 and expanded its Mexico footprint to 21 stores. Capex outlook shifted from increasing to stable. Bullish score declined from 85 to 78.
Guidance delta
FY2026 EPS guidance was raised from $7.10-$7.35 to $7.20-$7.45. Management reaffirmed plans to complete 2,000 Project Renovate and 2,250 Project Elevate remodels, open approximately 450 new stores in FY26 including additional Mexico locations, and pilot a delivery subscription program later in the year. The capex outlook moved from increasing to stable.
Key takeaways
- EPS of $2.00 beat the $1.89 consensus by 5.8%; revenue narrowly missed at $10.79B vs $10.81B expected.
- Same-store sales rose 2%, decelerating from 4.3% in Q4, but marked the fourth consecutive quarter of sequential comp growth.
- FY26 EPS guidance raised from $7.10-$7.35 to $7.20-$7.45.
- The $1 price point contributed ~70 bps to comp sales growth; delivery also added ~70 bps.
- 190 new U.S. stores opened in Q1; Mexico footprint expanded to 21 stores.
Management priorities
- Expanding the $1 Value Valley assortment and frozen $1 section to drive traffic and basket size.
- Scaling delivery from ~18,000 stores with a subscription pilot planned for later in the year.
- Completing 2,000 Project Renovate and 2,250 Project Elevate remodels in FY26.
- Opening approximately 450 new stores, including additional Mexico locations.
- Growing DG Media Network advertising revenue and third-party partnerships.
- Advancing AI operating system for enterprise-wide efficiency and continuing SKU rationalization.
Sources
- Earnings call transcript and parsed analysis · 2026-06-02T15:18:14.781363+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T16:31:31.263581+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T16:31:31.260785+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.